Autonomix Medical raises $2.6M via warrant inducement agreement

Go back to Autonomix Medical raises $2.6M via warrant inducement agreement

Autonomix Medical Enters into $2.6 Million Warrant Inducement Priced At-the-Market Under Nasdaq Rules

July 13, 2026 9:30 PM EDT

THE WOODLANDS, TX, July 13, 2026 (GLOBE NEWSWIRE) -- Autonomix Medical, Inc. (NASDAQ: AMIX) (Autonomix or the Company), a medical device company dedicated to advancing precision nerve-targeted treatments, today announced it has entered into a warrant inducement agreement with an investor (Investor) for the immediate exercise of certain outstanding warrants that the Company issued on November 19, 2025 (the November 2025 Warrants). Pursuant to a warrant inducement agreement, the Investor has agreed to exercise the outstanding November 2025 Warrants to purchase an aggregate of 428,731 shares of the Companys common stock at the amended and reduced exercise... More